Dawn Allen Sells 64,329 Shares of Haleon plc (LON:HLN) Stock

Haleon plc (LON:HLN - Get Free Report) insider Dawn Allen sold 64,329 shares of the company's stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of GBX 376 ($5.13), for a total value of £241,877.04 ($330,207.56).

Dawn Allen also recently made the following trade(s):

• On Monday, June 30th, Dawn Allen sold 19,565 shares of Haleon stock. The stock was sold at an average price of GBX 376 ($5.13), for a total transaction of £73,564.40 ($100,429.22).

Haleon Stock Performance

HLN stock traded up GBX 0.60 ($0.01) during mid-day trading on Thursday, reaching GBX 373.10 ($5.09). 15,214,528 shares of the stock traded hands, compared to its average volume of 26,117,240. The firm has a market capitalization of £33.67 billion, a PE ratio of 31.38, a P/E/G ratio of 1.49 and a beta of 0.19. The business has a 50-day moving average of GBX 395.64 and a two-hundred day moving average of GBX 387.05. Haleon plc has a 52 week low of GBX 322.20 ($4.40) and a 52 week high of GBX 419.50 ($5.73). The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36.

About Haleon

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.